Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijaya Rangavajhula

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|March 27, 2014
A risk-based auditing process for pharmaceutical manufacturersSusan Vargo, Bob Dana, Vijaya Rangavajhula, et al.
PDA Journal of Pharmaceutical Science and Technology|October 5, 2012
Considerations on Auditing and GxP Requirements along the Product LifecycleStephan Rönninger, Siegfried Schmitt, Vijaya Rangavajhula, et al.
Vaccine|February 21, 2015
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?Rebecca L Sheets, Vijaya Rangavajhula, Jeffrey K Pullen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|March 27, 2014
A risk-based auditing process for pharmaceutical manufacturersSusan Vargo, Bob Dana, Vijaya Rangavajhula, et al.
PDA Journal of Pharmaceutical Science and Technology|October 5, 2012
Considerations on Auditing and GxP Requirements along the Product LifecycleStephan Rönninger, Siegfried Schmitt, Vijaya Rangavajhula, et al.
Vaccine|February 21, 2015
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?Rebecca L Sheets, Vijaya Rangavajhula, Jeffrey K Pullen, et al.
Pageof 1